[HTML][HTML] Risk of heparinoid use in cosmetics and moisturizers in individuals vaccinated against severe acute respiratory syndrome coronavirus 2
K Yamamoto - Thrombosis Journal, 2021 - Springer
K Yamamoto
Thrombosis Journal, 2021•SpringerRecently, heparin-induced thrombocytopenia (HIT) after vaccination with the vaccines
manufactured by AstraZeneca and Pfizer–BioNTech has been published in the New
England Journal of Medicine. These reports state that heparin was not used around the
vaccination period in all cases. HIT after vaccination is more common in women; thus,
heparinoid use can be suspected to induce HIT.
manufactured by AstraZeneca and Pfizer–BioNTech has been published in the New
England Journal of Medicine. These reports state that heparin was not used around the
vaccination period in all cases. HIT after vaccination is more common in women; thus,
heparinoid use can be suspected to induce HIT.
Abstract
Recently, heparin-induced thrombocytopenia (HIT) after vaccination with the vaccines manufactured by AstraZeneca and Pfizer–BioNTech has been published in the New England Journal of Medicine. These reports state that heparin was not used around the vaccination period in all cases. HIT after vaccination is more common in women; thus, heparinoid use can be suspected to induce HIT.
Springer